Amniotic fluid antiphospholipid antibodies: potential role in antiphospholipid syndrome-independent aberrant implantation process.
Valentina BrunoMarzia NuccetelliCarlo TicconiAntonella BrunoFederica MartelliMaria Vittoria CapognaSergio BernardiniEmilio PiccioneAdalgisa PietropolliPublished in: Reproductive biology and endocrinology : RB&E (2019)
The presence of aPL in the AF (not related to APS) could reveal a potential clinical significance at maternal-fetal interface in selected pregnancy complications, in which an aberrant implantation process, and in turn an impaired fetal-maternal immune tolerance cross-talk, could occur.